Pharmalot - STAT

Pharmalot By Ed Silverman

Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity

Pharmalot By Ed Silverman

Biogen’s Alzheimer’s drug may only be cost effective at $2,500 a year

Pharmalot By Ed Silverman

U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production

Pharmalot By Ed Silverman

Pharmalittle: Pharma showers a key Democratic senator with cash; Lilly exec accused of altering factory documents

Pharmalot By Ed Silverman

Pharmalittle: Pfizer Covid-19 vaccine to generate $26 billion in 2021 sales; EMA reviews Sinovac Covid-19 vaccine

Pharmalot By Megan Thielking

STAT+ Conversations: An update from STAT’s Pharmalot

Pharmalot By Ed Silverman

European Commission fines a Merck KGaA unit for providing misleading info prior to a merger

Pharmalot By Ed Silverman

Pharmalittle: U.S. trade rep to talk with WTO about IP and Covid-19 vaccines; WHO’s Tedros plans to seek re-election

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Wyden goes back to the drawing board on drug pricing; Emergent undergoes an executive shake-up

Pharmalot By Ed Silverman

Pharmalittle: Biden issues ’empty call’ for drug pricing reform; FDA threatens to fine company for not posting trial results

Pharmalot By Ed Silverman

Pharmalittle: Pfizer Covid-19 pill could be ready by year-end; Warren urges SEC to probe Emergent CEO over stock sales

Pharmalot By Ed Silverman

Will India issue sidestep patents on a pair of pricey — but lifesaving — TB drugs?

Pharmalot By Ed Silverman

Pharmalittle: What will Biden say about drug pricing? U.S. trade rep meets with drug makers over WTO proposal

Paper cup pills nonadherent noncompliant

Pharmalot By Ed Silverman

Thanks to its Covid-19 response, pharma’s reputation among patient groups is climbing

Pharmalot By Ed Silverman

U.K. lawmakers want Boris Johnson to disclose emails with pharma about a WTO proposal on Covid-19 vaccines

Pharmalot By Ed Silverman

Down and out Down Under? Bristol Myers fights an ‘unreasonable’ Australian law over patents

Pharmalot By Ed Silverman

Pharmalittle: Emergent CEO sold stock before vaccine contamination was reported; Biden urged to support WTO proposal

Pharmalot By Ed Silverman

Millions sign petitions urging the U.S. to back a WTO proposal for greater Covid-19 vaccine access

Pharmalot By Ed Silverman

The price of a Vertex cystic fibrosis treatment stirs anger in Australia

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: CDC committee to vote on J&J Covid-19 vaccine; has the White House written off the J&J shot?

Pharmalot By Ed Silverman

‘There are no alternatives’: As Pfizer discontinues an old glaucoma drug, a small group of patients struggles to cope

Pharmalot By Ed Silverman

Pharmalittle: Europe looks to sue AstraZeneca over Covid-19 vaccine shortfalls; FDA skewers Emergent vaccine facility

Pharmalot By Ed Silverman

Most Read

For the first time, the FDA may fine a drug maker for failing to post clinical trial results

Did someone say patent thicket? AbbVie CEO to testify before Congress about drug pricing tactics

Biogen to expand access to its ALS drug, but move may come too late for some patients

Americans paid two to four times as much for some drugs as in three other countries

Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines

Rising wholesale drug prices really do matter to half of all commercially insured Americans

Global spending on medicines could hit $1.6 trillion by 2025 — and that doesn’t include Covid-19 vaccines

Gilead sues Russia over a compulsory license issued to a company making remdesivir

All Coverage

Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity

Biogen’s Alzheimer’s drug may only be cost effective at $2,500 a year

U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production

Pharmalittle: Pharma showers a key Democratic senator with cash; Lilly exec accused of altering factory documents

Pharmalittle: Pfizer Covid-19 vaccine to generate $26 billion in 2021 sales; EMA reviews Sinovac Covid-19 vaccine

STAT+ Conversations: An update from STAT’s Pharmalot

European Commission fines a Merck KGaA unit for providing misleading info prior to a merger

Pharmalittle: U.S. trade rep to talk with WTO about IP and Covid-19 vaccines; WHO’s Tedros plans to seek re-election

Up and down the ladder: The latest comings and goings

Pharmalittle: Wyden goes back to the drawing board on drug pricing; Emergent undergoes an executive shake-up

Pharmalittle: Biden issues ’empty call’ for drug pricing reform; FDA threatens to fine company for not posting trial results

Pharmalittle: Pfizer Covid-19 pill could be ready by year-end; Warren urges SEC to probe Emergent CEO over stock sales

Will India issue sidestep patents on a pair of pricey — but lifesaving — TB drugs?

Pharmalittle: What will Biden say about drug pricing? U.S. trade rep meets with drug makers over WTO proposal

Thanks to its Covid-19 response, pharma’s reputation among patient groups is climbing

U.K. lawmakers want Boris Johnson to disclose emails with pharma about a WTO proposal on Covid-19 vaccines

Down and out Down Under? Bristol Myers fights an ‘unreasonable’ Australian law over patents

Pharmalittle: Emergent CEO sold stock before vaccine contamination was reported; Biden urged to support WTO proposal

Millions sign petitions urging the U.S. to back a WTO proposal for greater Covid-19 vaccine access

The price of a Vertex cystic fibrosis treatment stirs anger in Australia

Up and down the ladder: The latest comings and goings

Pharmalittle: CDC committee to vote on J&J Covid-19 vaccine; has the White House written off the J&J shot?

‘There are no alternatives’: As Pfizer discontinues an old glaucoma drug, a small group of patients struggles to cope

Pharmalittle: Europe looks to sue AstraZeneca over Covid-19 vaccine shortfalls; FDA skewers Emergent vaccine facility

FDA issues scathing report of Emergent plant responsible for contaminated Covid-19 vaccines